Wilton Stephen B, Shibata Mariko A, Sondergaard Rachel, Cowan Karen, Semeniuk Lisa, Exner Derek V
Libin Cardiovascular Institute of Alberta, University of Calgary, Canada.
J Interv Card Electrophysiol. 2008 Dec;23(3):219-27. doi: 10.1007/s10840-008-9287-1. Epub 2008 Aug 8.
Benefit from cardiac resynchronization therapy (CRT) is likely influenced by the location of the left ventricular (LV) lead.
To evaluate the association of LV lead position with outcome after CRT.
Two-hundred and fifty patients with LV dysfunction, New York Heart Association (NYHA) class III (68%) or IV (32%) symptoms, and QRS durations > or =120 ms were followed for a median of 30 months post-CRT. LV lead position was categorized as anterior (n = 20, 8%), lateral (n = 128, 51%), or posterior (n = 102; 41%) using postero-anterior and lateral postoperative chest radiographs.
Median age was 69 years and most (68%) had ischemic LV dysfunction. Clinical response, defined by a > or =1 NYHA class reduction, was lower in patients with an anterior (30%) versus lateral (76%) or posterior (73%) lead position (p = 0.001). An anterior versus nonanterior position was independently associated with a two to three-fold higher risk for nonresponse to CRT, cardiovascular death, death from worsening heart failure or cardiac transplantation, and death from any cause. Repositioning of the LV lead from an anterior to a nonanterior position in seven patients who had not clinically responded to CRT after > or =6 months resulted in clinical improvement in all cases.
An anterior versus nonanterior LV lead position is independently associated with an increased likelihood of nonresponse to CRT and a higher risk of serious outcomes. Repositioning of an anteriorly placed LV lead to a nonanterior position should be considered in CRT nonresponders.
心脏再同步治疗(CRT)的获益可能受左心室(LV)导线位置的影响。
评估CRT后LV导线位置与治疗结果之间的关联。
对250例左心室功能不全、纽约心脏协会(NYHA)心功能III级(68%)或IV级(32%)症状且QRS时限≥120毫秒的患者进行CRT治疗后随访,随访时间中位数为30个月。使用术后后前位和侧位胸片将LV导线位置分为前位(n = 20,8%)、侧位(n = 128,51%)或后位(n = 102;41%)。
患者中位年龄为69岁,大多数(68%)有缺血性左心室功能不全。以NYHA心功能分级降低≥1级定义的临床反应,前位导线位置的患者(30%)低于侧位(76%)或后位(73%)导线位置的患者(p = 0.001)。前位与非前位位置独立相关,CRT无反应、心血管死亡、因心力衰竭恶化或心脏移植死亡以及任何原因死亡的风险高出两至三倍。在≥6个月后对CRT无临床反应的7例患者中,将LV导线从先前的前位重新放置到非前位位置,所有病例均出现临床改善。
LV导线前位与非前位位置独立相关,CRT无反应的可能性增加,严重后果风险更高。对于CRT无反应者,应考虑将先前置于前位的LV导线重新放置到非前位位置。